DLA Piper has advised TwoStep Therapeutics, Inc. TwoStep Therapeutics, Inc., a biotechnology company specializing in the development of multi-specific targeted therapies for solid tumors, has completed…
TwoStep Therapeutics Secures US$62.5 Million Series A Financing and IND Clearance for TS-104

























